Planta Med 2011; 77(17): 1932-1938
DOI: 10.1055/s-0030-1271199
Natural Product Chemistry
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

Isolation and Biological Activities of Phenanthroindolizidine and Septicine Alkaloids from the Formosan Tylophora ovata

Yue-Zhi Lee1 [*] , Chun-Wei Huang1 [*] , Cheng-Wei Yang1 , 2 , Hsing-Yu Hsu1 , Iou-Jiun Kang1 , Yu-Sheng Chao1 , Ih-Sheng Chen3 , Hwan-You Chang2 , Shiow-Ju Lee1
  • 1Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan
  • 2Institute of Molecular Medicine, National Tsing Hua University, Hsinchu, Taiwan
  • 3School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan
Further Information

Publication History

received October 15, 2010 revised January 26, 2011

accepted May 17, 2011

Publication Date:
04 July 2011 (online)

Preview

Abstract

An investigation of alkaloids present in the leaves and stems of Tylophora ovata led to the isolation of two new septicine alkaloids and one new phenanthroindolizidine alkaloid, tylophovatines A, B, C (1, 2, and 5), respectively, together with two known septicine and six known phenanthroindolizidine alkaloids. The structures of the new alkaloids 1, 2, and 5 were established by means of spectroscopic analyses. These eleven alkaloids show in vitro anti-inflammatory activities with IC50 values ranging from 84 nM to 20.6 µM through their suppression of nitric oxide production in RAW 264.7 cells stimulated by lipopolysaccharide and interferon-γ. Moreover, these substances display growth inhibition in HONE-1, NUGC-3, HepG2, SF-268, MCF-7, and NCI-H460 cancer cell lines, with GI50 values ranging from 4 nM to 24.2 µM. In addition, tylophovatine C (5) and 13a(S)-(+)-tylophorine (7) were found to exhibit potent in vivo anti-inflammation activities in a rat paw edema model. Finally, structure–activity relationships were probed by using the isolated phenanthroindolizidines and septicines. Phenanthroindolizidines are suggested to be divided into cytotoxic agents (e.g., 10 and 11) and anti-inflammation based anticancer agents (e.g., 59).

Supporting Information

References

1 Authors with equal contribution.

Associate Investigator Dr. Shiow-Ju Lee

Institute of Biotechnology and Pharmaceutical Research
National Health Research Institutes

35 Keyan Road

Zhunan Town

Miaoli County 35303

Taiwan

Phone: +886 37 24 61 66 ext. 3 57 15

Fax: +886 37 58 64 56

Email: slee@nhri.org.tw